-+ 0.00%
-+ 0.00%
-+ 0.00%

Calumet Stock Gets A Fresh Look As SAF Project Nears Launch

Simply Wall St·11/05/2026 10:44:08
Listen to the news
  • Calumet is moving ahead with its MaxSAF 150 sustainable aviation fuel project, scheduled for first half 2026 startup. Its Royal Purple branded motor oil lineup is set for a refreshed rollout from January 2027, highlighting a push toward higher value renewable fuels and specialty lubricants.
  • The combination of a large scale SAF project and a consumer facing Royal Purple refresh points to Calumet leaning harder into specialty, branded and renewable products that can carry different pricing and demand patterns than traditional commodity fuels.
  • We will now look at how Calumet's MaxSAF 150 sustainable aviation fuel project could reshape the broader investment narrative around the business.

Scan beyond Calumet and line up other specialty and renewables focused plays that could be setting up for the next move with the 19 high quality undiscovered gems.

Calumet Investment Narrative Recap

To own Calumet, you need to be comfortable that the shift toward renewable fuels and specialty products can offset an unprofitable base business and a leveraged balance sheet. In the short term, the story still leans on Montana Renewables running reliably and on regulatory support remaining intact. Recent stock volatility does not change that underlying operational focus.

The biggest near term swing factor is execution on MaxSAF 150 and existing renewable diesel output, which ties directly into cash generation and any room to reduce debt. The main risk is that regulatory support or industry pricing weakens, which would pressure margins and leave that leverage harder to manage.

The MaxSAF 150 sustainable aviation fuel project remains the most important recent development for this Calumet story. Management plans for first half 2026 startup and capacity of 120 million to 150 million gallons a year. That potential volume gives the business a clearer pathway to scale within a regulated, credit heavy segment.

For catalysts, this project sits at the center of most expectations for higher quality revenue and stronger EBITDA margins once it is running. The flip side is execution risk. Any delay, cost overrun, or weaker than expected SAF economics would ripple across cash flow, debt reduction plans, and the broader investment narrative.

Calumet's narrative projects US$5.5b revenue and US$549.6m earnings by 2029. This assumes 6.0% yearly revenue growth and an earnings improvement of about US$686m from a loss of US$136.8m today.

Uncover why Calumet's fair value indicates a 28% potential upside to its current price, which could narrow quickly.

NasdaqGS:CLMT 1-Year Stock Price Chart
NasdaqGS:CLMT 1-Year Stock Price Chart

Exploring Other Perspectives

Some of the most optimistic analysts frame MaxSAF as the real swing factor for Calumet, arguing that a successful shift toward roughly 200 million gallons of SAF capacity could justify revenue climbing toward US$6.0b and earnings of about US$503.5m by 2029. Those forecasts were set before this news, so opinions may change as fresh information emerges. Use the range of views as a prompt to explore several competing narratives yourself.

Explore 2 other Calumet fair value estimates, including one that suggests as much as 1508% upside from the current price!

The Verdict Is Yours

Don't just follow the ticker. Dig into the data and build a conviction that's truly your own.

Looking For More Investment Ideas Beyond Calumet?

If the Calumet story has you thinking about portfolio gaps, it can help to line up a few focused stock lists and see how other businesses stack up on quality, income, or balance sheet strength.

  • For investors hunting for underappreciated quality, start by scanning a curated group of companies that screen as potentially mispriced on fundamentals with the 35 high quality undervalued stocks.
  • If dependable income is a priority, filter for companies targeting stronger balance sheets and higher yields using the 5 dividend fortresses.
  • For a focus on resilience, compare Calumet with businesses that score well on financial robustness and low risk profiles through the 31 resilient stocks with low risk scores.